Amicus Therapeutics Inc (FOLD): שווי כולל של נכסי החברה
Amicus Therapeutics dominates the enzyme therapy niche for rare pathologies, solidifying its global status in the US and Europe. On GURU.Markets, total assets by ROA demonstrate financial stability, with the latest reading standing at 866.13. Growth is based on strategic alliances with scientific centers, while commercial success is driven by revolutionary methods for correcting defective proteins to save patients.
פילוחי מדדים מקיפים ואנליטיקה עבור Amicus Pharma (FOLD)
The full utilization of Amicus Therapeutics (FOLD) biotechnological production capacities for rare disease drugs is directly reflected in the asset trends by ROA. This indicator, calculated inversely through return on assets, combines capital and liabilities, allowing investors to assess the real value of resources and the financial stability of the business amid fierce market competition.